These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2346037)

  • 1. The metabolic disposition of an orally active pyridyl thiadiazinone cardiotonic agent (MPTD) in rat and baboon.
    McKillop D; Pickup KJ; Swaisland AJ; Holmes BF
    Xenobiotica; 1990 Apr; 20(4):401-15. PubMed ID: 2346037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey.
    Salmon J; Coussediere D; Cousty C; Raynaud JP
    J Steroid Biochem; 1983 Aug; 19(2):1223-34. PubMed ID: 6887930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of Taurolin].
    Steinbach-Lebbin C; Ganz AJ; Chang A; Waser PG
    Arzneimittelforschung; 1982; 32(12):1542-6. PubMed ID: 6891594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, metabolism, and excretion of [¹⁴C]GDC-0449 (vismodegib), an orally active hedgehog pathway inhibitor, in rats and dogs: a unique metabolic pathway via pyridine ring opening.
    Yue Q; Chen YH; Mulder T; Deese A; Takahashi R; Rudewicz PJ; Reynolds M; Solon E; Hop CE; Wong H; Khojasteh SC
    Drug Metab Dispos; 2011 Jun; 39(6):952-65. PubMed ID: 21363998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
    Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
    Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physiological disposition of the anti-tussive agent, 1,2,3,4a,9b-hexahydro-8,9b-dimethyl-4-[3-(4-methylpiperazin-1-yl)propionamido]dibenzofuran-3-one dihydrochloride Azipranone, in man, rat, dog and baboon.
    Daniel JW; James GW; Rowlands DA; Taylor JB
    Xenobiotica; 1978 May; 8(5):321-9. PubMed ID: 96617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and biotransformation of 3-cyan-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in the rat].
    Vagaday M; Kunter U; Labes D; Hagen V; Böhme B; Franke P
    Pharmazie; 1994 Jan; 49(1):41-7. PubMed ID: 8140129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
    Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
    Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD; Draffan GH; Dunsire JP; Zimmer A
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism and disposition of 14C-indolidan, a potent and orally active cardiotonic agent, in four species of laboratory animals.
    Bernstein JR; Franklin RB
    Xenobiotica; 1988 Dec; 18(12):1335-45. PubMed ID: 3245229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bioavailability and disposition of [14C]omapatrilat in healthy subjects.
    Malhotra BK; Iyer RA; Soucek KM; Behr D; Liao WC; Mitroka JG; Kaul S; Cohen MB; Knupp CA
    J Clin Pharmacol; 2001 Aug; 41(8):833-41. PubMed ID: 11504270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of l-3-[(dimethylamino)-(m-dioxan-5-yl)methyl]pyridine in man.
    Rubin A; Dhahir PH; Crabtree RE; Henry DP
    Drug Metab Dispos; 1979; 7(3):149-54. PubMed ID: 38085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
    Borondy PE; Michniewicz BM
    Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.